SlideShare a Scribd company logo
Pharmacy access to the
emergency contraceptive
pill (ECP): women’s
knowledge, attitudes and
use
Melissa Hobbs, Angela Taft, Lisa Amir, Kay Stewart, Julia
Shelley, Anthony Smith, Colin Chapman, Safeera Hussainy
Collaboration
___________________________
•Research team:
- Angela Taft, Lisa Amir, Anthony Smith (La
Trobe University)
- Colin Chapman, Kay Stewart, Safeera
Hussainy (Monash University)
- Julia Shelley (Deakin University)
• Industry partners:
- Sexual Health & Family Planning Australia
- Bayer Schering Pharma
• Funded by ARC Linkage grant
Background
___________________________
• Rates of unplanned and unwanted pregnancies
in Australia are a public health concern
• Significantly higher teenage birth rate in
Australia (17.3 births per 1000 women)
compared with some other developed nations -
Japan (4.6), Switzerland (5.5), Korea (2.9)
(ABS, 2008; UNICEF, 2001)
• 17% of women aged 20-29 pregnant as a
teenager (Smith AMA et al., 2003)
Unintended pregnancy
Background
___________________________
• 23.8% of Australian men experienced condom
failure in previous 12 months (Smith AMA et al.,
2003)
• 53% of women 16-19 years at risk of unplanned
pregnancy used condoms as a contraceptive
method (Richters et al., 2003)
• Medical, emotional, social and financial impact of
unintended pregnancy is very significant
Unintended pregnancy (cont)
Background
___________________________
• Estimated that at least 50% of unintended
pregnancies end in abortion
• Australia’s estimated abortion rate (19.7 per
1000 females aged 15-44 years) is higher
compared with rates in Germany (7.7), The
Netherlands (8.7) or Finland (10.9)
(AIHW NPSU, 2005)
• Among women 16-59 years, 22.6% have had 1
or more abortions (Smith et al., 2003)
Abortion
Progestogen-only ECP
___________________________
• Available from health services with prescription
since July 2002
• Available over-the-counter (OTC) since January
2004
• Postinor 1 & 2, Levonelle 2 & Norlevo
• Since pharmacy access, very few population-
based studies on women’s knowledge, attitudes
and use
Study aim
___________________________
• To examine the provision of the ECP in
Australia – assess women’s
understanding, use, satisfaction with and
acceptance of the ECP, particularly since
OTC
Method
___________________________
• Cross-sectional design
• 632 Australian women aged 16-35 years
• Computer assisted telephone interview survey
(CATI)
• Conducted between May – August 2008
Eligibility
___________________________
• Woman between ages of 16 and 35 years
• Speak and understand sufficient English
• If more than 1 eligible resident in household,
CATI program randomly selects person
Sampling procedure
___________________________
• National survey
• Based on RDD strategy
• 88% of Australian households have fixed-line
telephone service (Australian Communications &
Media Authority, 2009)
Sampling (cont)
___________________________
• Stratified by state and territory
• Sample size calculated based on estimated
proportion of ECP use from 2 nationally
representative surveys:
•Australian Study of Health & Relationships
(ASHR) 2001/02 – 19.2% women 16-59
years ever used ECP
•Australian Longitudinal Study of Women’s
Health (ALSWH) 2006 – 9.8% women 28-33
years used ECP over previous 4 years
Results
___________________________
• Response rate 74.4%
• Sample weighted on basis of:
•household size (number of eligible women in
household)
•to match Australian population for age and
area of residence
Participant characteristics
___________________________
• 25% aged between 30-34 years
• 82% born in Australia
• 94% spoke English at home
• 38% married
• 59% living in capital city
• 29% had completed university degree
• 69% were employed
Results: use
___________________________
• 26% (n=166) had ever used ECP
• 62% (n=100) of users obtained from pharmacy
• 68% (n=68) who obtained from pharmacy was
without prescription
• Largest subgroup (42%) used between ages 20-
24 years (n=68)
• 3% (n=5) used at age 14-15 years
• Majority (69%) used ECP only once (n=112)
Results: use (cont)
___________________________
• 70% said ECP was convenient to obtain
• Only 1 woman had supply of ECP at home for
future use
• Majority (79%) said it would be somewhat or
very easy to pay for ECP (about AUD $25)
• Main reason for non-use was did not think at risk
for pregnancy (57%)
Knowledge about ECP
Women n = 569
Statement about ECP True
n (%)
False
n (%)
Don’t Know
n (%)
ECP stops a pregnancy from starting 363 (63.7) 156 (27.4) 51 (8.9)
ECP is an abortion pill 181 (31.7) 354 (62.2) 35 (6.1)
ECP is also known as RU-486 98 (17.3) 144 (25.2) 327 (57.5)
You can take ECP up to 3 months after
becoming pregnant 10 (1.7) 504 (88.6) 55 (9.6)
You can’t get ECP at all in Australia 7 (1.3) 524 (92.0) 38 (6.7)
You can get ECP from a pharmacy without
a prescription 273 (48.0) 215 (37.7) 82 (14.4)
ECP can prevent you from getting an STD 5 (0.9) 553 (97.1) 11 (2.0)
ECP is more effective than regular
contraceptive pills at preventing pregnancy 55 (9.7) 446 (78.3) 68 (12.0)
After taking ECP you don’t need to use
contraception until your next period 1 (1.9) 527 (92.6) 31 (5.4)
Results: Knowledge and use
___________________________
0
10
20
30
40
1 2 3 4 5 6 7 8 9 10
Knowledge score
%
non-use
use
Women n = 525
n %
How safe is the ECP for the health of women?
Unsafe/very unsafe 93 17.7
Neither safe nor unsafe 153 29.1
Safe/very safe 237 45.2
Don’t know 41 7.9
How effective is the ECP at preventing pregnancy?
Ineffective/very ineffective 33 6.3
Neither effective nor ineffective 50 9.6
Effective/very effective 386 73.5
Don’t know 55 10.4
If a woman uses the ECP it will be harder for her to get pregnant in the future
Yes 67 12.7
No 356 67.7
Don’t know 103 19.6
If a woman does not know she is pregnant and uses the ECP, it will cause
problems such as birth defects or a miscarriage
Yes 318 60.5
No 78 14.8
Don’t know 129 24.5
Attitudes / beliefs about the ECP
Attitudes / beliefs about the ECP
Women n = 525
n %
When the ECP became available OTC from Australian pharmacies
in January 2004, it was a positive step for women
Disagree/strongly disagree 59 11.3
Neither agree nor disagree 90 17.1
Agree/strongly agree 373 71.1
Don’t know 2 0.4
The availability of the ECP will lead to more women having sex
without using contraception
Disagree/strongly disagree 238 45.4
Neither agree nor disagree 82 15.7
Agree/strongly agree 200 38.1
Don’t know 4 0.8
Men would be less likely to use a condom if they knew that their
female partners could get the ECP whenever they needed it
Disagree/strongly disagree 197 37.5
Neither agree nor disagree 102 19.5
Agree/strongly agree 224 42.6
Don’t know 2 0.4
Results: pharmacy experience
(n=68)
___________________________
• Of those who obtained ECP OTC, 62% said they
had enough privacy
• 24% were given contraceptive advice and 19%
given advice about sexually transmitted
infections (STIs) from pharmacist
• Less than half said it was pharmacist role to give
contraceptive (47%) and STI advice (49%)
Results: multivariate analysis
___________________________
• Women who believed OTC availability of ECP good step
for women significantly more likely to use ECP (OR 2.20;
95% CI 1.04 – 4.66)
• Women with ‘poor’ knowledge of ECP significantly less
likely to use ECP (OR 0.28; 95% CI 0.09 – 0.77)
• Women 20-29 years (OR 2.58; 95% CI 1.29 – 5.19) and
30-35 years (OR 3.16; 95% CI 1.47 – 6.80) more likely to
use ECP than women 16-19 years
• Women in de facto relationship (OR 2.21; 95% CI 1.27 –
3.85), in relationship but not living with partner (OR 2.46;
95% CI 1.31 – 4.63) or single (OR 2.40; 95% CI 1.33 –
4.34) more likely to use ECP than married women
Strengths and limitations
___________________________
• First national population-based Australian study
exploring women’s use of ECP
• CATI methodology has many advantages over
other data collection methods
• High usage of mobile phones in Australia and
‘mobile-only’ households more often younger
• Some groups of people excluded from telephone
surveys (homeless; those whose first language
is not English; those in institutions)
Conclusion
___________________________
• Women have high level of awareness of ECP
but inadequate specific knowledge
• More information and education required
• Relatively high prevalence of use of ECP in
Australia compared with other industrialised
countries
• Teenage women less likely to use ECP so
important to target this group

More Related Content

What's hot

Issues in contraception
Issues in contraceptionIssues in contraception
Issues in contraceptionchaimingcheng
 
Recent advances in hormonal contraception malini
Recent advances in hormonal contraception maliniRecent advances in hormonal contraception malini
Recent advances in hormonal contraception malini
Malini Kv
 
Contraception
ContraceptionContraception
Contraception
muktadirmahin
 
Long acting reversible contraception
Long acting reversible contraceptionLong acting reversible contraception
Long acting reversible contraception
Alia Syarmila
 
Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...
Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...
Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...
Lifecare Centre
 
emergency contraception update
emergency contraception updateemergency contraception update
emergency contraception update
mzttm
 
About emergency contraception
About emergency contraceptionAbout emergency contraception
About emergency contraception
Shyam Mandal
 
Ovral-L (Ethinyl Estradiol and Levonorgestrel Tablets)
Ovral-L (Ethinyl Estradiol and Levonorgestrel Tablets)Ovral-L (Ethinyl Estradiol and Levonorgestrel Tablets)
Ovral-L (Ethinyl Estradiol and Levonorgestrel Tablets)
Clearsky Pharmacy
 
Overview of contraception
Overview of contraceptionOverview of contraception
Overview of contraceptionobsgynhsnz
 
Cntraception & Family planning
Cntraception & Family planningCntraception & Family planning
Cntraception & Family planning
Geeta Yadav
 
METHODS OF CONTRACEPTION
METHODS OF CONTRACEPTION METHODS OF CONTRACEPTION
METHODS OF CONTRACEPTION
Aboubakr Elnashar
 
Emergency contraception
Emergency contraceptionEmergency contraception
Emergency contraceptionraj kumar
 
Long acting hormonal contraceptives
Long acting hormonal contraceptivesLong acting hormonal contraceptives
Long acting hormonal contraceptives
Akiseku Adeniyi
 
Contraception Update April 2019
Contraception Update April 2019Contraception Update April 2019
Contraception Update April 2019
Kervindran Mohanasundaram
 
Dr rabi the estrogen free pill
Dr rabi  the estrogen free pillDr rabi  the estrogen free pill
Dr rabi the estrogen free pill
Rabi Satpathy
 
Oral contraceptives
Oral contraceptivesOral contraceptives
Oral contraceptives
velspharmd
 
Optimizing The outcome of Threatened Abortion Dr Sharda Jain
Optimizing The outcome of Threatened Abortion  Dr Sharda Jain Optimizing The outcome of Threatened Abortion  Dr Sharda Jain
Optimizing The outcome of Threatened Abortion Dr Sharda Jain
Lifecare Centre
 
Contraception, Hormones, Progestogens: Update : Dr. Jyoti agarwal Dr. Sharda ...
Contraception, Hormones, Progestogens: Update : Dr. Jyoti agarwal Dr. Sharda ...Contraception, Hormones, Progestogens: Update : Dr. Jyoti agarwal Dr. Sharda ...
Contraception, Hormones, Progestogens: Update : Dr. Jyoti agarwal Dr. Sharda ...
Lifecare Centre
 

What's hot (20)

Issues in contraception
Issues in contraceptionIssues in contraception
Issues in contraception
 
Recent advances in hormonal contraception malini
Recent advances in hormonal contraception maliniRecent advances in hormonal contraception malini
Recent advances in hormonal contraception malini
 
Emergency Contraception
Emergency ContraceptionEmergency Contraception
Emergency Contraception
 
Emergancy Contraceptives
Emergancy ContraceptivesEmergancy Contraceptives
Emergancy Contraceptives
 
Contraception
ContraceptionContraception
Contraception
 
Long acting reversible contraception
Long acting reversible contraceptionLong acting reversible contraception
Long acting reversible contraception
 
Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...
Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...
Dienogest+ Ethinyl Estradiol Role in oral contraception & Acne Dr Sharda Jain...
 
emergency contraception update
emergency contraception updateemergency contraception update
emergency contraception update
 
About emergency contraception
About emergency contraceptionAbout emergency contraception
About emergency contraception
 
Ovral-L (Ethinyl Estradiol and Levonorgestrel Tablets)
Ovral-L (Ethinyl Estradiol and Levonorgestrel Tablets)Ovral-L (Ethinyl Estradiol and Levonorgestrel Tablets)
Ovral-L (Ethinyl Estradiol and Levonorgestrel Tablets)
 
Overview of contraception
Overview of contraceptionOverview of contraception
Overview of contraception
 
Cntraception & Family planning
Cntraception & Family planningCntraception & Family planning
Cntraception & Family planning
 
METHODS OF CONTRACEPTION
METHODS OF CONTRACEPTION METHODS OF CONTRACEPTION
METHODS OF CONTRACEPTION
 
Emergency contraception
Emergency contraceptionEmergency contraception
Emergency contraception
 
Long acting hormonal contraceptives
Long acting hormonal contraceptivesLong acting hormonal contraceptives
Long acting hormonal contraceptives
 
Contraception Update April 2019
Contraception Update April 2019Contraception Update April 2019
Contraception Update April 2019
 
Dr rabi the estrogen free pill
Dr rabi  the estrogen free pillDr rabi  the estrogen free pill
Dr rabi the estrogen free pill
 
Oral contraceptives
Oral contraceptivesOral contraceptives
Oral contraceptives
 
Optimizing The outcome of Threatened Abortion Dr Sharda Jain
Optimizing The outcome of Threatened Abortion  Dr Sharda Jain Optimizing The outcome of Threatened Abortion  Dr Sharda Jain
Optimizing The outcome of Threatened Abortion Dr Sharda Jain
 
Contraception, Hormones, Progestogens: Update : Dr. Jyoti agarwal Dr. Sharda ...
Contraception, Hormones, Progestogens: Update : Dr. Jyoti agarwal Dr. Sharda ...Contraception, Hormones, Progestogens: Update : Dr. Jyoti agarwal Dr. Sharda ...
Contraception, Hormones, Progestogens: Update : Dr. Jyoti agarwal Dr. Sharda ...
 

Similar to 3.4.2 Melissa Hobbs

3.4.1 Safeera Hussainy
3.4.1 Safeera Hussainy3.4.1 Safeera Hussainy
Family Planning Methods.pdf
Family Planning Methods.pdfFamily Planning Methods.pdf
Family Planning Methods.pdf
Anindita Choudhury
 
Report on sexual activity and contraceptive methods for female ( June 2014)
Report on sexual activity and contraceptive methods for female ( June 2014)Report on sexual activity and contraceptive methods for female ( June 2014)
Report on sexual activity and contraceptive methods for female ( June 2014)
W&S Market Research
 
Report on Sexual Activities and Contraceptive Methods for Female in Vietnam 2014
Report on Sexual Activities and Contraceptive Methods for Female in Vietnam 2014Report on Sexual Activities and Contraceptive Methods for Female in Vietnam 2014
Report on Sexual Activities and Contraceptive Methods for Female in Vietnam 2014
MACROMILL SOUTH EAST ASIA, INC.
 
Ijpsr14 05-11-015
Ijpsr14 05-11-015Ijpsr14 05-11-015
Ijpsr14 05-11-015alem teka
 
Quality of care in obstetric services in rural South India-evidence from two ...
Quality of care in obstetric services in rural South India-evidence from two ...Quality of care in obstetric services in rural South India-evidence from two ...
Quality of care in obstetric services in rural South India-evidence from two ...
IPHIndia
 
Single Embryo Transfer
Single Embryo TransferSingle Embryo Transfer
Single Embryo Transfer
Dr.Laxmi Agrawal Shrikhande
 
Misconceptions about Oral Contraceptive Pill Used Among Women at Primary Heal...
Misconceptions about Oral Contraceptive Pill Used Among Women at Primary Heal...Misconceptions about Oral Contraceptive Pill Used Among Women at Primary Heal...
Misconceptions about Oral Contraceptive Pill Used Among Women at Primary Heal...
iosrjce
 
Low Cost IVF Presentation
Low Cost IVF PresentationLow Cost IVF Presentation
Low Cost IVF Presentation
Dr.Laxmi Agrawal Shrikhande
 
Patient centered contraception
Patient centered contraceptionPatient centered contraception
Patient centered contraception
Sagarika Roy
 
JC action trial.pptx
JC action trial.pptxJC action trial.pptx
JC action trial.pptx
dawsonfinger1
 
10 mistakes a infertility specialist makes new converted
10 mistakes a infertility specialist makes new converted10 mistakes a infertility specialist makes new converted
10 mistakes a infertility specialist makes new converted
Dr. Abha Majumdar
 
Austin Journal of Women's Health
Austin Journal of Women's Health Austin Journal of Women's Health
Austin Journal of Women's Health
Austin Publishing Group
 
Professor Soo Downe
Professor Soo DowneProfessor Soo Downe
Professor Soo Downe
Hannah Stockdale
 
Family Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MSFamily Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MSNikole Gettings
 
Scientific Sessions 2015: HIV Pre-exposure prophylaxis
Scientific Sessions 2015: HIV Pre-exposure prophylaxisScientific Sessions 2015: HIV Pre-exposure prophylaxis
Scientific Sessions 2015: HIV Pre-exposure prophylaxis
Sri Lanka College of Sexual Health and HIV Medicine
 
An investigation of the proportion of unintended pregnancies and associated f...
An investigation of the proportion of unintended pregnancies and associated f...An investigation of the proportion of unintended pregnancies and associated f...
An investigation of the proportion of unintended pregnancies and associated f...
Gwinyai Masukume
 
Slides from Focus on Frailty 2019 conference main plenary sessions
Slides from Focus on Frailty 2019 conference main plenary sessionsSlides from Focus on Frailty 2019 conference main plenary sessions
Slides from Focus on Frailty 2019 conference main plenary sessions
Health Innovation Wessex
 
Challenges - In management of infertility
Challenges - In management of infertilityChallenges - In management of infertility
Challenges - In management of infertility
DrRokeyaBegum
 

Similar to 3.4.2 Melissa Hobbs (20)

3.4.1 Safeera Hussainy
3.4.1 Safeera Hussainy3.4.1 Safeera Hussainy
3.4.1 Safeera Hussainy
 
Family Planning Methods.pdf
Family Planning Methods.pdfFamily Planning Methods.pdf
Family Planning Methods.pdf
 
Report on sexual activity and contraceptive methods for female ( June 2014)
Report on sexual activity and contraceptive methods for female ( June 2014)Report on sexual activity and contraceptive methods for female ( June 2014)
Report on sexual activity and contraceptive methods for female ( June 2014)
 
Report on Sexual Activities and Contraceptive Methods for Female in Vietnam 2014
Report on Sexual Activities and Contraceptive Methods for Female in Vietnam 2014Report on Sexual Activities and Contraceptive Methods for Female in Vietnam 2014
Report on Sexual Activities and Contraceptive Methods for Female in Vietnam 2014
 
Ijpsr14 05-11-015
Ijpsr14 05-11-015Ijpsr14 05-11-015
Ijpsr14 05-11-015
 
Quality of care in obstetric services in rural South India-evidence from two ...
Quality of care in obstetric services in rural South India-evidence from two ...Quality of care in obstetric services in rural South India-evidence from two ...
Quality of care in obstetric services in rural South India-evidence from two ...
 
Single Embryo Transfer
Single Embryo TransferSingle Embryo Transfer
Single Embryo Transfer
 
Misconceptions about Oral Contraceptive Pill Used Among Women at Primary Heal...
Misconceptions about Oral Contraceptive Pill Used Among Women at Primary Heal...Misconceptions about Oral Contraceptive Pill Used Among Women at Primary Heal...
Misconceptions about Oral Contraceptive Pill Used Among Women at Primary Heal...
 
Low Cost IVF Presentation
Low Cost IVF PresentationLow Cost IVF Presentation
Low Cost IVF Presentation
 
Patient centered contraception
Patient centered contraceptionPatient centered contraception
Patient centered contraception
 
JC action trial.pptx
JC action trial.pptxJC action trial.pptx
JC action trial.pptx
 
10 mistakes a infertility specialist makes new converted
10 mistakes a infertility specialist makes new converted10 mistakes a infertility specialist makes new converted
10 mistakes a infertility specialist makes new converted
 
Austin Journal of Women's Health
Austin Journal of Women's Health Austin Journal of Women's Health
Austin Journal of Women's Health
 
Professor Soo Downe
Professor Soo DowneProfessor Soo Downe
Professor Soo Downe
 
Family Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MSFamily Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MS
 
pepe512
pepe512pepe512
pepe512
 
Scientific Sessions 2015: HIV Pre-exposure prophylaxis
Scientific Sessions 2015: HIV Pre-exposure prophylaxisScientific Sessions 2015: HIV Pre-exposure prophylaxis
Scientific Sessions 2015: HIV Pre-exposure prophylaxis
 
An investigation of the proportion of unintended pregnancies and associated f...
An investigation of the proportion of unintended pregnancies and associated f...An investigation of the proportion of unintended pregnancies and associated f...
An investigation of the proportion of unintended pregnancies and associated f...
 
Slides from Focus on Frailty 2019 conference main plenary sessions
Slides from Focus on Frailty 2019 conference main plenary sessionsSlides from Focus on Frailty 2019 conference main plenary sessions
Slides from Focus on Frailty 2019 conference main plenary sessions
 
Challenges - In management of infertility
Challenges - In management of infertilityChallenges - In management of infertility
Challenges - In management of infertility
 

More from Australian Women's Health Network 6th Conference 2010

4.8.4 Bronwyn Silver
4.8.4 Bronwyn Silver4.8.4 Bronwyn Silver
4.8.3 Pam Price1
4.8.3  Pam Price14.8.3  Pam Price1
4.8 session 4.8
4.8 session 4.84.8 session 4.8
4.8.2 Caterina Bortolot
4.8.2 Caterina Bortolot4.8.2 Caterina Bortolot
4.7.3 Nikki Greenway
4.7.3 Nikki Greenway4.7.3 Nikki Greenway
4.7.2 Rochelle Hine
4.7.2  Rochelle Hine4.7.2  Rochelle Hine
4.7.1 Charmaine Power
4.7.1 Charmaine Power4.7.1 Charmaine Power
4.5.6 Mary Ann Lancaster
4.5.6 Mary Ann Lancaster4.5.6 Mary Ann Lancaster
4.5.5 Carolyn Enks
4.5.5 Carolyn Enks4.5.5 Carolyn Enks
4.5.4 Kim Morey
4.5.4  Kim Morey4.5.4  Kim Morey
4.5.3 Susan Brumby
4.5.3 Susan Brumby4.5.3 Susan Brumby
4.5.2 Cathy Wheel
4.5.2 Cathy Wheel4.5.2 Cathy Wheel
4.5.1 Rebecca Eckert
4.5.1 Rebecca Eckert4.5.1 Rebecca Eckert
4.5 Session 4.5
4.5 Session 4.54.5 Session 4.5
4.1.4 Dea Delaney
4.1.4 Dea Delaney4.1.4 Dea Delaney
4.1.3 Pauline Gwatirisa
4.1.3 Pauline Gwatirisa4.1.3 Pauline Gwatirisa
4.1.1 Karin Swift
4.1.1  Karin Swift4.1.1  Karin Swift
4.1.2 Marilyn Beaumont
4.1.2 Marilyn Beaumont4.1.2 Marilyn Beaumont
4.6.5 Siri May
4.6.5 Siri May4.6.5 Siri May

More from Australian Women's Health Network 6th Conference 2010 (20)

4.8.4 Bronwyn Silver
4.8.4 Bronwyn Silver4.8.4 Bronwyn Silver
4.8.4 Bronwyn Silver
 
4.8.3 Pam Price1
4.8.3  Pam Price14.8.3  Pam Price1
4.8.3 Pam Price1
 
4.8 session 4.8
4.8 session 4.84.8 session 4.8
4.8 session 4.8
 
4.8.2 Caterina Bortolot
4.8.2 Caterina Bortolot4.8.2 Caterina Bortolot
4.8.2 Caterina Bortolot
 
4.7.3 Nikki Greenway
4.7.3 Nikki Greenway4.7.3 Nikki Greenway
4.7.3 Nikki Greenway
 
4.7.2 Rochelle Hine
4.7.2  Rochelle Hine4.7.2  Rochelle Hine
4.7.2 Rochelle Hine
 
4.7.1 Charmaine Power
4.7.1 Charmaine Power4.7.1 Charmaine Power
4.7.1 Charmaine Power
 
4.7 session 4.7
4.7 session 4.74.7 session 4.7
4.7 session 4.7
 
4.5.6 Mary Ann Lancaster
4.5.6 Mary Ann Lancaster4.5.6 Mary Ann Lancaster
4.5.6 Mary Ann Lancaster
 
4.5.5 Carolyn Enks
4.5.5 Carolyn Enks4.5.5 Carolyn Enks
4.5.5 Carolyn Enks
 
4.5.4 Kim Morey
4.5.4  Kim Morey4.5.4  Kim Morey
4.5.4 Kim Morey
 
4.5.3 Susan Brumby
4.5.3 Susan Brumby4.5.3 Susan Brumby
4.5.3 Susan Brumby
 
4.5.2 Cathy Wheel
4.5.2 Cathy Wheel4.5.2 Cathy Wheel
4.5.2 Cathy Wheel
 
4.5.1 Rebecca Eckert
4.5.1 Rebecca Eckert4.5.1 Rebecca Eckert
4.5.1 Rebecca Eckert
 
4.5 Session 4.5
4.5 Session 4.54.5 Session 4.5
4.5 Session 4.5
 
4.1.4 Dea Delaney
4.1.4 Dea Delaney4.1.4 Dea Delaney
4.1.4 Dea Delaney
 
4.1.3 Pauline Gwatirisa
4.1.3 Pauline Gwatirisa4.1.3 Pauline Gwatirisa
4.1.3 Pauline Gwatirisa
 
4.1.1 Karin Swift
4.1.1  Karin Swift4.1.1  Karin Swift
4.1.1 Karin Swift
 
4.1.2 Marilyn Beaumont
4.1.2 Marilyn Beaumont4.1.2 Marilyn Beaumont
4.1.2 Marilyn Beaumont
 
4.6.5 Siri May
4.6.5 Siri May4.6.5 Siri May
4.6.5 Siri May
 

Recently uploaded

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 

Recently uploaded (20)

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 

3.4.2 Melissa Hobbs

  • 1. Pharmacy access to the emergency contraceptive pill (ECP): women’s knowledge, attitudes and use Melissa Hobbs, Angela Taft, Lisa Amir, Kay Stewart, Julia Shelley, Anthony Smith, Colin Chapman, Safeera Hussainy
  • 2. Collaboration ___________________________ •Research team: - Angela Taft, Lisa Amir, Anthony Smith (La Trobe University) - Colin Chapman, Kay Stewart, Safeera Hussainy (Monash University) - Julia Shelley (Deakin University) • Industry partners: - Sexual Health & Family Planning Australia - Bayer Schering Pharma • Funded by ARC Linkage grant
  • 3. Background ___________________________ • Rates of unplanned and unwanted pregnancies in Australia are a public health concern • Significantly higher teenage birth rate in Australia (17.3 births per 1000 women) compared with some other developed nations - Japan (4.6), Switzerland (5.5), Korea (2.9) (ABS, 2008; UNICEF, 2001) • 17% of women aged 20-29 pregnant as a teenager (Smith AMA et al., 2003) Unintended pregnancy
  • 4. Background ___________________________ • 23.8% of Australian men experienced condom failure in previous 12 months (Smith AMA et al., 2003) • 53% of women 16-19 years at risk of unplanned pregnancy used condoms as a contraceptive method (Richters et al., 2003) • Medical, emotional, social and financial impact of unintended pregnancy is very significant Unintended pregnancy (cont)
  • 5. Background ___________________________ • Estimated that at least 50% of unintended pregnancies end in abortion • Australia’s estimated abortion rate (19.7 per 1000 females aged 15-44 years) is higher compared with rates in Germany (7.7), The Netherlands (8.7) or Finland (10.9) (AIHW NPSU, 2005) • Among women 16-59 years, 22.6% have had 1 or more abortions (Smith et al., 2003) Abortion
  • 6. Progestogen-only ECP ___________________________ • Available from health services with prescription since July 2002 • Available over-the-counter (OTC) since January 2004 • Postinor 1 & 2, Levonelle 2 & Norlevo • Since pharmacy access, very few population- based studies on women’s knowledge, attitudes and use
  • 7. Study aim ___________________________ • To examine the provision of the ECP in Australia – assess women’s understanding, use, satisfaction with and acceptance of the ECP, particularly since OTC
  • 8. Method ___________________________ • Cross-sectional design • 632 Australian women aged 16-35 years • Computer assisted telephone interview survey (CATI) • Conducted between May – August 2008
  • 9. Eligibility ___________________________ • Woman between ages of 16 and 35 years • Speak and understand sufficient English • If more than 1 eligible resident in household, CATI program randomly selects person
  • 10. Sampling procedure ___________________________ • National survey • Based on RDD strategy • 88% of Australian households have fixed-line telephone service (Australian Communications & Media Authority, 2009)
  • 11. Sampling (cont) ___________________________ • Stratified by state and territory • Sample size calculated based on estimated proportion of ECP use from 2 nationally representative surveys: •Australian Study of Health & Relationships (ASHR) 2001/02 – 19.2% women 16-59 years ever used ECP •Australian Longitudinal Study of Women’s Health (ALSWH) 2006 – 9.8% women 28-33 years used ECP over previous 4 years
  • 12. Results ___________________________ • Response rate 74.4% • Sample weighted on basis of: •household size (number of eligible women in household) •to match Australian population for age and area of residence
  • 13. Participant characteristics ___________________________ • 25% aged between 30-34 years • 82% born in Australia • 94% spoke English at home • 38% married • 59% living in capital city • 29% had completed university degree • 69% were employed
  • 14. Results: use ___________________________ • 26% (n=166) had ever used ECP • 62% (n=100) of users obtained from pharmacy • 68% (n=68) who obtained from pharmacy was without prescription • Largest subgroup (42%) used between ages 20- 24 years (n=68) • 3% (n=5) used at age 14-15 years • Majority (69%) used ECP only once (n=112)
  • 15. Results: use (cont) ___________________________ • 70% said ECP was convenient to obtain • Only 1 woman had supply of ECP at home for future use • Majority (79%) said it would be somewhat or very easy to pay for ECP (about AUD $25) • Main reason for non-use was did not think at risk for pregnancy (57%)
  • 16. Knowledge about ECP Women n = 569 Statement about ECP True n (%) False n (%) Don’t Know n (%) ECP stops a pregnancy from starting 363 (63.7) 156 (27.4) 51 (8.9) ECP is an abortion pill 181 (31.7) 354 (62.2) 35 (6.1) ECP is also known as RU-486 98 (17.3) 144 (25.2) 327 (57.5) You can take ECP up to 3 months after becoming pregnant 10 (1.7) 504 (88.6) 55 (9.6) You can’t get ECP at all in Australia 7 (1.3) 524 (92.0) 38 (6.7) You can get ECP from a pharmacy without a prescription 273 (48.0) 215 (37.7) 82 (14.4) ECP can prevent you from getting an STD 5 (0.9) 553 (97.1) 11 (2.0) ECP is more effective than regular contraceptive pills at preventing pregnancy 55 (9.7) 446 (78.3) 68 (12.0) After taking ECP you don’t need to use contraception until your next period 1 (1.9) 527 (92.6) 31 (5.4)
  • 17. Results: Knowledge and use ___________________________ 0 10 20 30 40 1 2 3 4 5 6 7 8 9 10 Knowledge score % non-use use
  • 18. Women n = 525 n % How safe is the ECP for the health of women? Unsafe/very unsafe 93 17.7 Neither safe nor unsafe 153 29.1 Safe/very safe 237 45.2 Don’t know 41 7.9 How effective is the ECP at preventing pregnancy? Ineffective/very ineffective 33 6.3 Neither effective nor ineffective 50 9.6 Effective/very effective 386 73.5 Don’t know 55 10.4 If a woman uses the ECP it will be harder for her to get pregnant in the future Yes 67 12.7 No 356 67.7 Don’t know 103 19.6 If a woman does not know she is pregnant and uses the ECP, it will cause problems such as birth defects or a miscarriage Yes 318 60.5 No 78 14.8 Don’t know 129 24.5 Attitudes / beliefs about the ECP
  • 19. Attitudes / beliefs about the ECP Women n = 525 n % When the ECP became available OTC from Australian pharmacies in January 2004, it was a positive step for women Disagree/strongly disagree 59 11.3 Neither agree nor disagree 90 17.1 Agree/strongly agree 373 71.1 Don’t know 2 0.4 The availability of the ECP will lead to more women having sex without using contraception Disagree/strongly disagree 238 45.4 Neither agree nor disagree 82 15.7 Agree/strongly agree 200 38.1 Don’t know 4 0.8 Men would be less likely to use a condom if they knew that their female partners could get the ECP whenever they needed it Disagree/strongly disagree 197 37.5 Neither agree nor disagree 102 19.5 Agree/strongly agree 224 42.6 Don’t know 2 0.4
  • 20. Results: pharmacy experience (n=68) ___________________________ • Of those who obtained ECP OTC, 62% said they had enough privacy • 24% were given contraceptive advice and 19% given advice about sexually transmitted infections (STIs) from pharmacist • Less than half said it was pharmacist role to give contraceptive (47%) and STI advice (49%)
  • 21. Results: multivariate analysis ___________________________ • Women who believed OTC availability of ECP good step for women significantly more likely to use ECP (OR 2.20; 95% CI 1.04 – 4.66) • Women with ‘poor’ knowledge of ECP significantly less likely to use ECP (OR 0.28; 95% CI 0.09 – 0.77) • Women 20-29 years (OR 2.58; 95% CI 1.29 – 5.19) and 30-35 years (OR 3.16; 95% CI 1.47 – 6.80) more likely to use ECP than women 16-19 years • Women in de facto relationship (OR 2.21; 95% CI 1.27 – 3.85), in relationship but not living with partner (OR 2.46; 95% CI 1.31 – 4.63) or single (OR 2.40; 95% CI 1.33 – 4.34) more likely to use ECP than married women
  • 22. Strengths and limitations ___________________________ • First national population-based Australian study exploring women’s use of ECP • CATI methodology has many advantages over other data collection methods • High usage of mobile phones in Australia and ‘mobile-only’ households more often younger • Some groups of people excluded from telephone surveys (homeless; those whose first language is not English; those in institutions)
  • 23. Conclusion ___________________________ • Women have high level of awareness of ECP but inadequate specific knowledge • More information and education required • Relatively high prevalence of use of ECP in Australia compared with other industrialised countries • Teenage women less likely to use ECP so important to target this group